The clinicopathological and genetic differences among gastric cancer patients with no recurrence, early recurrence, and late recurrence after curative surgery

Meng Chao Chen, Hsuan Yu Su, Yen Hao Su, Kuo Hung Huang, Wen Liang Fang, Chii Wann Lin, Ming Huang Chen, Yee Chao, Su Shun Lo, Anna Fen-Yau Li, Chew Wun Wu

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Abstract

Background: To date, few reports have investigated the genetic alterations and clinicopathological features among gastric cancer (GC) patients with no tumor recurrence, early recurrence, and late recurrence following curative surgery. Methods: A total of 473 GC patients undergoing curative surgery were included. The clinicopathological characteristics, patient prognosis, recurrence patterns, and genetic alterations were compared between GC patients with early recurrence and late recurrence. Results: Among the 473 GC patients, 119 had early recurrence (<2 years) and 45 had late recurrence (≥2 years). Patients with early recurrence had tumor size larger than 5 cm, fewer superficial-type tumors, more lymphovascular invasion, more advanced pathological T and N categories and Tumor, Node, Metastasis (TNM) stages, and worse 5-year overall survival than patients with late recurrence and no recurrence. For intestinal-type GC, patients with no tumor recurrence had more Helicobacter pylori infection than patients with early recurrence and late recurrence; for diffuse-type GC patients, the frequency of PIK3CA amplification was the highest in early recurrence, followed by late recurrence and no recurrence. GC patients with single-site recurrence had more ARID1A mutations than those with multiple-site recurrence. Multivariate analysis demonstrated that age, tumor recurrence, and pathological N categories were independent prognostic factors. Conclusion: PIK3CA amplifications were more common in diffuse-type GC with early recurrence, whereas ARID1A mutations were more common in patients with single-site recurrence. Targeted therapy and immunotherapy might be helpful for these patients.

Original languageEnglish
Pages (from-to)57-64
Number of pages8
JournalJournal of the Chinese Medical Association
Volume86
Issue number1
DOIs
Publication statusPublished - Jan 1 2023

Keywords

  • ARID1A
  • Early recurrence
  • Gastric cancer
  • Genetic alteration
  • Late recurrence
  • PIK3CA amplification

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'The clinicopathological and genetic differences among gastric cancer patients with no recurrence, early recurrence, and late recurrence after curative surgery'. Together they form a unique fingerprint.

Cite this